What cancers can Dabrafenib Mesylate treat?
Dabrafenib mesylate in combination with trametinib dimethyl sulfoxide is used to treat cancer patients with a certain BRAF gene mutation, such as: Treating undifferentiated thyroid cancer that is loca
Nov 7，2023 Drugs
The benefits, chemical property, and toxicity of Fucoidan
Fucoidan has been used as a medicinal nutritional supplement in Asia for a long time due to its medicinal characteristics, including anti-cancer action.
Nov 7，2023 Biochemical Engineering
The Pharmacokinetics and toxicity of Mesalazine
Mesalazine is a medication commonly used for the treatment of inflammatory bowel disease. Over the years, there has been significant research on the toxicity and pharmacokinetics of this drug.
Nov 7，2023 API
A useful anti-inflammatory agent: Mesalazine
Mesalazine is an anti-inflammatory agent, structurally related to salicylates, which is active in inflammatory bowel disease.
Nov 7，2023 API
The rising star of the beauty industry——Polyglutamic acid
Polyglutamic acid (PGA) is a humectant and powerful hydrator that can attract moisture and seal it in. It is made up of a group of glutamic acid molecules.
Nov 6，2023 Biochemical Engineering
The applications and side effects of Entecavir
Entecavir is an analog of 2′-deoxyguanosine. This compound is approved for the treatment of hepatitis B infection with compensated or decompensated liver disease in adults.
Nov 6，2023 API
Stanolone: biochemistry, physiology, and clinical implications
Stanolone, synthesized via SRD5A, has diverse clinical applications in hormone-related disorders and cancer treatment.
Nov 6，2023 API
NADP, Disodium Salt: physiological role, activities and applications
NADP, Disodium Salt is a vital coenzyme in cellular metabolism, redox reactions, and gene expression regulation with promising therapeutic potential.
Nov 6，2023 API
The catalytic properties of Tetrabutyl titanate
Tetrabutyl titanate is commonly used as a catalyst. It is able to improve the adhesion of coatings, rubber, and plastics to metal surfaces.
Nov 6，2023 Organic reagents
Adverse reactions of Crizotinib in the treatment of Inflammatory myofibroblastic tumour (IMT)
The most common adverse reactions (≥35%) in pediatric patients were vomiting, nausea, diarrhea, abdominal pain, rash, vision disorder, upper respiratory tract infection, cough, pyrexia, musculoskeleta
Nov 3，2023 Drugs